Research Grade Biosimilar Antibodies

Low endotoxin levels
Hot Target Coverage
Validated binding activity

What are Biosimilar Antibodies?

Biosimilar antibodies are research-grade antibodies that are highly similar in structure, function and sequences to the approved original therapeutic antibodies. They are produced through recombination technology and have the same variable regions from the corresponding therapeutic antibodies, which making them reliable and more cost-effective research tools and alternative reagents in drug development and basic research.

CUSABIO has successfully expressed and validated many research-grade biosimilar antibodies, covering a variety of popular targets. All these research-grade biosimilar antibodies can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.

Why Choose CUSABIO Biosimilar Antibodies?

Identical Variable Region Sequence

Our biosimilar antibodies are recombinantly expressed in mammalian cells with unmodified variable and Fc regions identical to the approved therapeutic antibodies.

Broad Range of Targets

We offer over 200 ready-to-use biosimilar antibodies covering key targets, including immune checkpoints, tumor drivers, and neurological markers.

Validated Binding Activity

Each batch is ELISA-validated for strong target binding and comes with an EC50 value for reliable performance.

Stable Supplies of Various Scale

We offer stable supply of research-grade biosimilar antibodies from ul to g level, proving multiple options to customers.

Common Application Scenarios

icon

Mechanism Research and Functional Validation

Serve as highly similar research tools for in vitro assessment of biological activities such as cytotoxicity and blocking effects of antibody drugs, enabling in-depth investigation into their mechanisms of action.

icon

Drug Development and Quality Control Analysis

Used as critical reference standards or surrogate materials in the development of pharmacokinetic (PK) and immunogenicity (ADA) assays, facilitating method validation and bioequivalence evaluation.

icon

Assay and Diagnostic Development

Function as reliable positive controls in Flow Cytometry, IHC, and other detection platforms, or are utilized in the development of companion diagnostics to ensure assay specificity and accuracy.

icon

Preclinical In Vivo Efficacy Evaluation

With formulations suitable for in vivo administration, they can be directly applied in animal models for efficacy assessment and dose exploration, providing a foundation for preclinical research.

Product Catalog

Don't see your desired biosimilar in the catalog below? We also offer a High-Throughput Recombinant Antibody Production Service to develop custom antibodies for any target – at the same competitive price point. Learn more

Code Product Name
CSB-RA017765MB1HU PEAR1 (SV001 Biosimilar) Recombinant Monoclonal Antibody
CSB-RA009939MB1HU GRN (AG-01 Biosimilar) Recombinant Monoclonal Antibody
CSB-RA044639I1m GD3 ganglioside (Ecromeximab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA320223MA1BQE pagA Antigen (Obiltoxaximab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA336462MA1FKZ spa (Omodenbamab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA853494MA2HU FCRL5 (DFRF4539A (RG-7598) Biosimilar) Recombinant Monoclonal Antibody
CSB-RA011880MA1HU ITGB1 (OS-2966 Biosimilar) Recombinant Monoclonal Antibody
CSB-RA898797MA1HU TAG-72 (Minretumomab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA005983MA2HU CRLF2 (Solrikitug Biosimilar) Recombinant Monoclonal Antibody
CSB-RA621524MA1HU KLRB1 (Rezorstobart Biosimilar) Recombinant Monoclonal Antibody
CSB-RA015950MA2HU NOTCH2 (Tarextumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA006045MA3HU CSF2 (Namilumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA004953MA1HU CD7 (Grisnilimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA801822MA2HU VTCN1 (Puxitatug Biosimilar) Recombinant Monoclonal Antibody
CSB-RA704410MA3HU MUC16 (Sofituzumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA867155MA2HU SLITRK6 (Sirtratumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA154670MA1HU IgE (Talizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA592139MA1HU OxLDL (Orticumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA012928MA1HU LIF (Falbikitug Biosimilar) Recombinant Monoclonal Antibody
CSB-RA357716MA1FKZ Toxin A (Tosatoxumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA004943MA2HU CD52 (Gatralimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA012871MA1HU LEPR (Mibavademab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA016331MA1HU OLR1 (Golocdacimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA003658MA1HU C2 (Empasiprubart Biosimilar) Recombinant Monoclonal Antibody
CSB-RA011050MA2HU IFNG (Fontolizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA011864MA2HU ITGA2 (Vatelizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA004900MA1HU CD22 (Moxetumomab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA007765MA2HU ERBB3 (Duligotuzumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA872537MA2HU IL21 (Avizakimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA023462MA2HU TGM2 (Zampilimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA011661MA2HU IL4R (Manfidokimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA003995MA2HU C5 (Crovalimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA621767MA2HU SELPLG (Neihulizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA023446MA1HU TGFB1 (Metelimumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA984018MA1DO IL-31 (Lokivetmab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA011087MA3HU IGF1R (Figitumumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA890691MA2HU STEAP1 (Vandortuzumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA16849MA2HU IGHE (Quilizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA004895MA2HU CD200 (Samalizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA618886MA1HU LRRC32 (Livmoniplimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA007717MA2HU EPCAM (Tucotuzumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA159341MB20HU EGFR (Tomuzotuximab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA017647MB13HU PCSK9 (Frovocimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA614985MB1HU AMHR2 (Murlentamab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA675446MB18HU TIGIT (Tamgiblimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA012719MB16HU LAG3 (Ieramilimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA619964MB54HU PDCD1 (Acrixolimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA878862MB3HU DLL4 (Enoticumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA887154MB1HU RSPO3 (Rosmantuzumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA015215MB3HU MUC1 (Gatipotuzumab Biosimilar) Recombinant Monoclonal Antibody

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2026 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1